Want to see MGX full AI Analyst Report?
Metagenomi, Inc. (MGX) Stock Statistics & Valuation Metrics
Total Valuation
Metagenomi, Inc. has a market cap or net worth of $26.80M. The enterprise value is -$38.13M.
- Market Cap
- $26.80M
- Enterprise Value
- -$38.13M
Share Statistics
Metagenomi, Inc. has 37,777,103 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 37,777,103
- Owned by Insiders
- 10.12%
- Owned by Institutions
- 9.00%
Financial Efficiency
Metagenomi, Inc.’s return on equity (ROE) is -0.55 and return on invested capital (ROIC) is -46.99%.
- Return on Equity (ROE)
- -0.55
- Return on Assets (ROA)
- -0.40
- Return on Invested Capital (ROIC)
- -46.99%
- Return on Capital Employed (ROCE)
- -0.48
- Revenue Per Employee
- 223.10K
- Profits Per Employee
- -777.59K
- Employee Count
- 113
- Asset Turnover
- 0.11
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Metagenomi, Inc. is -0.29. Metagenomi, Inc.’s PEG ratio is 0.05.
- PE Ratio
- -0.29
- PS Ratio
- 2.01
- PB Ratio
- 0.24
- Price to FCF
- -0.32
- Price to Operating Cash Flow
- -0.32
- PEG Ratio
- 0.05
Income Statement
In the last 12 months, Metagenomi, Inc. had revenue of 25.21M and earned -87.87M in profits. Earnings per share was -2.36.
- Revenue
- 25.21M
- Gross Profit
- 19.89M
- Operating Income
- -96.01M
- Pretax Income
- -87.93M
- Net Income
- -87.87M
- EBITDA
- -82.61M
- Earnings Per Share (EPS)
- -2.36
Cash Flow
In the last 12 months, operating cash flow was -85.49M and capital expenditures -309,000, giving a free cash flow of -85.80M billion.
- Operating Cash Flow
- -85.49M
- Free Cash Flow
- -85.80M
- Free Cash Flow per Share
- -2.28
Dividends & Yields
Metagenomi, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -319.87%
- Earnings Yield
- -349.56%
Stock Price Statistics
- Beta
- 1.10
- 52-Week Price Change
- -68.06%
- 50-Day Moving Average
- 1.00
- 200-Day Moving Average
- 1.26
- Relative Strength Index (RSI)
- 28.41
- Average Volume (3m)
- 155.27K
Important Dates
Metagenomi, Inc. upcoming earnings date is Nov 18, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 10, 2026
- Next Earnings Date
- Nov 18, 2026
- Ex-Dividend Date
- ―
Financial Position
Metagenomi, Inc. as a current ratio of 7.22, with Debt / Equity ratio of 25.64%
- Current Ratio
- 7.22
- Quick Ratio
- 7.22
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.01
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Metagenomi, Inc. has paid -58.00K in taxes.
- Income Tax
- -58.00K
- Effective Tax Rate
- 0.00
Enterprise Valuation
Metagenomi, Inc. EV to EBITDA ratio is -0.29, with an EV/FCF ratio of -0.30.
- EV to Sales
- 1.88
- EV to EBITDA
- -0.29
- EV to Free Cash Flow
- -0.30
- EV to Operating Cash Flow
- -0.30
Balance Sheet
Metagenomi, Inc. has $120.66M in cash and marketable securities with $37.72M in debt, giving a net cash position of $82.94M billion.
- Cash & Marketable Securities
- $120.66M
- Total Debt
- $37.72M
- Net Cash
- $82.94M
- Net Cash Per Share
- $2.20
- Tangible Book Value Per Share
- $2.99
Margins
Gross margin is 74.29%, with operating margin of -741.58%, and net profit margin of -689.20%.
- Gross Margin
- 74.29%
- Operating Margin
- -741.58%
- Pretax Margin
- -690.60%
- Net Profit Margin
- -689.20%
- EBITDA Margin
- -652.52%
- EBIT Margin
- -690.60%
Analyst Forecast
The average price target for Metagenomi, Inc. is $7.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- $7.00
- Price Target Upside
- 887.31% Upside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 3
- Revenue Growth Forecast
- -59.84%
- EPS Growth Forecast
- -5.97%
Scores
- Smart Score
- ―
- AI Score
- 43
